| Literature DB >> 35571218 |
Xiang-Nan Li1, Jing-Xi Wang1, Qing Wei2, Xian-Bo Yu3, Yu-Tao Zhou1, Xiao-Yan Ma1, Na Zhao1, Bin Lu1.
Abstract
Objective: Delayed enhancement cardiac CT is a reliable tool for the diagnosis of left atrial appendage thrombus but limited for scanning heterogeneity. We aimed to explore the improvement of the 1 and 3-min delay phase at the diagnostic level to detect left atrial appendage thrombus, in order to set up a reasonable CT scanning scheme. Materials andEntities:
Keywords: atrial fibrillation; computed tomography angiography; echocardiography; thrombosis; transesophageal
Year: 2022 PMID: 35571218 PMCID: PMC9095922 DOI: 10.3389/fcvm.2022.847163
Source DB: PubMed Journal: Front Cardiovasc Med ISSN: 2297-055X
FIGURE 1A study flow-chart of patients inclusion and exclusion. Cardiac CT with complete period include the arterial enhancement phase, 1 and 3-min delay phase.
Study characteristics of the of the overall populations.
| Characteristics | |
| Age | 58.3 ± 12.2 |
|
| |
| Male | 227 (69.0%) |
| Female | 102 (31.0%) |
| BMI (kg/m2) | 25.7 ± 4.0 |
| Hypertension | 173 (52.6%) |
| Diabetes mellitus | 42 (12.8%) |
| Hypercholesterolemia | 135 (41.0%) |
| NYHA ≥ Level 3 | 42 (12.8%) |
| Peripheral vascular disease | 43 (13.1%) |
| History of stroke/TIA | 42 (12.8%) |
|
| |
| 0 | 28 (8.5%) |
| 1 | 51 (15.5%) |
| ≥ 2 | 162 (76%) |
|
| |
| Paroxysmal atrial fibrillation | 177 (53.8%) |
| Persistent atrial fibrillation | 152 (46.2%) |
| Left atrial anteroposterior diameter (mm)[ | 39.0 ± 6.5 |
Unless noted, all except age data are numbers of patients, with the percentage of patients in parentheses.
*BMI, body mass index; TIA, Transient ischemic attack.
FIGURE 2(A) The arterial enhanced phase shows the filling defect (solid star) at the tip of the left atrial appendage and the uneven filling (solid triangle) of contrast medium in the rest of the structure. (B) The tip of left atrial appendage still showed filling defect, while the rest were filled evenly at 1-min delayed. (C) Thrombus at the tip of the left atrial appendage was confirmed at 3-min delayed. (D) The tip of left atrial appendage was old thrombus (red arrow) and the rest of the structure were severe SEC (hollow triangle) at TEE. (E) Image of 3D ultrasound.
FIGURE 3(A) The arterial enhanced phase shows the filling defect (solid star) at the tip and uneven filling in the body of the left atrial appendage. (B) Tip and body of left atrial appendage both showed filling defect at 1-min delayed. (C) Thrombus at the tip and body (mural and calcified marked with white arrow) of the left atrial appendage was confirmed at 3-min delayed. (D) The tip of left atrial appendage was fresh sludge thrombus (red arrow) at TEE in two chamber section. (E) After 6-weeks of regular oral anticoagulation treatment, re-examination of TEE showed no thrombus detected.
FIGURE 4Different diagnostic efficiency of the arterial enhancement phase, 1-min delay phase, and 3-min delay phase for the left atrial thrombus detection.
Diagnostic Performance of the arterial enhanced phase, 1-min delayed and 3-min delayed phase for left atrial appendage thrombus detection.
| AUC | Accuracy | Sensitivity | Specificity | PPV | NPV | |
| Arterial enhanced phase | 0.77 (0.74–0.80) | 0.58 (0.53–0.63) | 1.00 (1.00–1.00) | 0.54 (0.48–0.59) | 0.17 (0.16–0.19) | 1.00 (1.00–1.00) |
| 1-min delayed phase | 0.96 (0.95–0.98) | 0.93 (0.91–0.96) | 1.00 (1.00–1.00) | 0.93 (0.90–0.95) | 0.57 (0.48–0.67) | 1.00 (1.00–1.00) |
| 3-min delayed phase | 1.00 (1.00–1.00) | 1.00 (1.00–1.00) | 1.00 (1.00–1.00) | 1.00 (1.00–1.00) | 1.00 (1.00–1.00) | 1.00 (1.00–1.00) |
Data are expressed as value (%) and 95% confidence interval.
AUC, Area under curve; PPV, positive predictive value; NPV, negative predictive value.
Confusion matrix in the diagnosis of left atrial appendage thrombus by cardiac CT using TEE as the gold standard.
| Cardiac CT | Arterial enhancement phase | 1-min delay phase | 3-min delay phase | ||||
| Thrombosis | No thrombosis | Thrombosis | No thrombosis | Thrombosis | No thrombosis | ||
| TEE | Thrombosis | 29 | 0 | 29 | 0 | 29 | 0 |
| No thrombosis | 139 | 161 | 22 | 278 | 0 | 300 | |
Univariate and multivariate Logistic regression analysis of 1-min delay phase filling defect.
| Risk factors | Logistic regression analysis | |||||
| Univariate | multivariate | |||||
| OR | 95% CI | OR | 95% CI | |||
| Reduced cardiac function | 0.01 | 1.46 | 0.047–0.056 | 0.01 | 1.07 | 1.014–1.125 |
| Increased CHA2DS2-VAScscore | < 0.0001 | 5.087 | 2.844–9.098 | < 0.0001 | 4.88 | 2.672–8.905 |
| Type of the atrial fibrillation | 0.04 | 1.75 | 0.030–0.059 | 0.13 | 1.59 | 0.867–2.909 |
| Left atrial enlargement | 0.02 | 1.06 | 1.008–1.106 | 0.01 | 1.07 | 1.014–1.125 |
All statistically significant baseline risk factors were calculated in logistic regression analysis, Reduced cardiac function classification were defined as NYHA ≥ Level 3; increased CHA2DS2-VAScscore were defined as male ≥ 2 or female ≥ 3; left atrial enlargement were defined as left atrial anteroposterior diameter ≥ 40 mm; OR, Odds Ratio; 95% CI, 95% confidence interval.
Scanning quality and the radiation dose.
| Cardiac CT | Enhancement phase | 1-min delayed | 3-min delayed | Total |
| Average CT value of left atrial appendage (HU) | 368.3 ± 147.0 | 158.9 ± 87.1 | 109.0 ± 90.8 | NA |
| DLP (mGy•cm) | 383.6 ± 326.7 | 125.9 ± 98.1 | 107.8 ± 58.1 | 520.4 ± 485.6 |
| Effective dose (mSv) | 5.3 ± 3.6 | 1.7 ± 1.3 | 1.5 ± 0.8 | 7.3 ± 6.8 |
DLP, dose-length product.